Osimertinib is used to treat NSCLC with the EGFR T790M mutation. It’s a targeted therapy for this type of lung cancer. You got it in two dose sizes, 40 mg and 80 mg, and it comes in these film-coated tablets.
The usual dose is 80 mg. You take it once a day, by mouth, and it don’t matter if you eat or not before you take it. Each bottle holds 30 tablets.
Osimertinib stops this EGFR T790M protein from doing its thing, which is kind of like telling the cancer cells to behave. It’s an oral med, meaning you take it by mouth, and you should stick to the schedule your doctor gives you. How long and how well it works can vary from person to person.
